Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/2/13 → 06/26/15 |
Funding
- Novartis Pharmaceuticals Corporation: $6,875.00
A Single-Arm, Multicenter, Nilotinib Treatment-Free Remission Study in Patients with BCR-ABL1 Positive Chronic Myelogenous Leukemia in Chronic Phase Who Have Achieved Durable Minimal Residual Disease (MRD) Status on First Line Nilotinib...
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Wood, Sylvia K (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
- Masood, Aisha (CoPI)
Project: Research